C3ai, INC Form 4 insider transactions

NYSE
C3.ai's Chief Financial Officer, Hitesh Lath, disclosed the acquisition of shares through RSU vesting and an Employee Stock Purchase Plan, alongside a sale to cover tax obligations.
NYSE
C3.ai Director John E. Hyten reported the cash settlement of 2,500 vested Restricted Stock Units at $8.91 per share.
NYSE
C3.ai's Executive Chairman, Thomas M. Siebel, disclosed recent transactions involving Class A Common Stock, including RSU vesting, tax-related sales, and gifts.
NYSE
C3.ai's Chief Financial Officer, Hitesh Lath, was granted 100,000 stock options with an exercise price of $8.65, vesting over three years.
NYSE
Thomas M. Siebel, Executive Chairman of C3.ai, Inc., reported the vesting of restricted stock units and subsequent share transactions, including sales for tax obligations and gifts.
NYSE
C3.ai Executive Chairman Thomas M. Siebel exercised options and sold 511,732 shares of Class A Common Stock for a weighted-average price of $11.66, as part of a pre-arranged 10b5-1 trading plan.
NYSE
C3.ai Executive Chairman Thomas M. Siebel reported recent transactions including RSU vesting, a tax-related stock sale, and a gift of shares.
NYSE
C3.ai Director John E. Hyten reported the sale of 2,500 Class A Common Stock shares at $13.53 each following the vesting of 5,000 Restricted Stock Units.
NYSE
C3.ai Executive Chairman Thomas M. Siebel filed a Form 4 detailing planned stock option exercises and subsequent sales of Class A Common Stock under a Rule 10b5-1 trading plan.
NYSE
C3.ai CEO Stephen Ehikian reported the vesting of Restricted Stock Units, subsequent sales for tax obligations, and a gift of shares, resulting in a shift in beneficial ownership.
NYSE
C3.ai Executive Chairman Thomas M. Siebel sold 532,832 shares of Class A Common Stock in mid-December 2025 through a pre-arranged Rule 10b5-1 trading plan.
NYSE
C3.ai Director John E. Hyten sold 2,500 shares of Class A Common Stock for $14.65 per share as part of a pre-arranged Rule 10b5-1 plan.
NYSE
C3.ai's Chief Financial Officer, Hitesh Lath, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations.
NYSE
C3.ai director Michael Wayne Clayville was granted 34,091 stock options with a $15.92 exercise price, vesting over two years.
NYSE
C3.ai Executive Chairman Thomas M. Siebel reported significant equity transactions, including RSU conversions, new equity grants, and a tax-related share sale.
NYSE
C3.ai Executive Chairman Thomas M. Siebel reported the vesting and subsequent sale of shares for tax obligations, along with gift transfers, as detailed in a recent Form 4 filing.
NYSE
C3.ai Executive Chairman Thomas M. Siebel sold 543,706 shares of Class A Common Stock for a weighted-average price of $15.24 per share, executed under a Rule 10b5-1 trading plan.
NYSE
C3.ai Executive Chairman Thomas Siebel reported the vesting of RSUs, subsequent sale for tax obligations, and a gift of shares, alongside changes in indirect holdings.
NYSE
C3.ai Executive Chairman Thomas M. Siebel sold 554,802 shares of Class A Common Stock for approximately $10.4 million, executed under a pre-arranged 10b5-1 trading plan.
NYSE
C3.ai Director Stephen Ward Jr. was granted 30,264 stock options with an exercise price of $19.16, vesting over two years based on board meeting attendance.
NYSE
C3.ai Director KR Sridhar was granted 28,628 stock options with a $19.16 exercise price, vesting over two years tied to board meeting attendance.
NYSE
C3.ai Director D. Bruce Sewell received 30,264 stock options with a $19.16 exercise price, vesting over two years contingent on board meeting attendance.
NYSE
C3.ai Director Alan S. Murray was granted 28,628 stock options with an exercise price of $19.16, vesting over two years.
NYSE
C3.ai Director Condoleezza Rice exercised stock options and received a new grant of options, increasing her beneficial ownership.
NYSE
C3.ai, Inc. director Michael G. McCaffery was granted 32,309 stock options with an exercise price of $19.16.
NYSE
C3.ai Director Jim H. Snabe was granted 28,628 stock options with an exercise price of $19.16, vesting over two years contingent on board service and meeting attendance.
NYSE
C3.ai Director John E. Hyten was granted 28,628 stock options with an exercise price of $19.16, vesting quarterly over two years contingent on board meeting attendance.
NYSE
C3.ai Director Richard C. Levin was granted 28,628 stock options with an exercise price of $19.16, vesting over two years contingent on board meeting attendance.
NYSE
C3.ai's EVP & Chief Commercial Officer, Robert David Schilling, reported the acquisition of vested Restricted Stock Units and subsequent sales of Class A Common Stock.
NYSE
C3.ai's CEO, Stephen Bradley Ehikian, was granted over 2.4 million shares in Restricted Stock Units and stock options, aligning his incentives with long-term company performance.